Bus FCIS - Living Cell Company Sec
| LVCLF Stock | USD 0.01 0.0008 18.60% |
Insider
Bus FCIS is Company Sec of Living Cell Technologies
| Age | 58 |
| Phone | 61 3 8689 9997 |
| Web | https://www.lctglobal.com |
Living Cell Management Efficiency
The company has return on total asset (ROA) of (0.3084) % which means that it has lost $0.3084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7233) %, meaning that it generated substantial loss on money invested by shareholders. Living Cell's management efficiency ratios could be used to measure how well Living Cell manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Eric Tse | Sino Biopharmaceutical Ltd | 27 | |
| Oren Hershkovitz | Enlivex Therapeutics | 47 | |
| Shachar CPA | Enlivex Therapeutics | 47 | |
| Pr MD | Enlivex Therapeutics | 68 | |
| Simon Beaudoin | Defence Therapeutics | 39 | |
| Sigal Arad | Enlivex Therapeutics | N/A | |
| Moutih Rafei | Defence Therapeutics | 41 | |
| Carrie Cesarone | Defence Therapeutics | 58 | |
| Sebastien Plouffe | Defence Therapeutics | 51 | |
Management Performance
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 |
Living Cell Technologies Leadership Team
Elected by the shareholders, the Living Cell's board of directors comprises two types of representatives: Living Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Living. The board's role is to monitor Living Cell's management team and ensure that shareholders' interests are well served. Living Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Living Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Belinda Bartolo, Chief Officer | ||
| Bus FCIS, Company Sec | ||
| BSc BSc, Interim Officer | ||
| Daya Uka, Chief Officer |
Living Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Living Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (428.70) % | |||
| Current Valuation | 12.53 M | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 33.99 % | |||
| Price To Earning | (31.67) X | |||
| Price To Book | 6.96 X | |||
| Price To Sales | 5,587 X | |||
| Revenue | 3.4 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Living Pink Sheet
Living Cell financial ratios help investors to determine whether Living Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Living with respect to the benefits of owning Living Cell security.